Handling procedures for low and intermediate toxicity drug compounds are much less controlled than those of a potent nature, largely because their pharmacological effects, if exposed to, are less severe. Typically substances of this nature will have pharmacological effects when used in concentrations over 10mg/Kg. Low and intermediate toxicity drug...
Potent and Highly Potent Drug Compounds
Potent and Highly Potent Drug Compounds have distinct properties that mean they need to be handled in a much more controlled manner. These compounds will not be commonly handled on the open bench and require definite controlled handling procedures in order to minimise scientist exposure. Category 3: Potent Compounds A...
Categorisation of Drug Compounds
The basis of the categorisation of drug compounds is inherent to their toxicity. Drug entities are initially classified in terms of their respective toxicity and potency characteristics. Toxicity can be determined in various ways, such as through observations in pre-clinical toxicological investigations and in clinical trials. Other factors are: Mechanism...
Exposure Potential to Drug Compounds in the Laboratory
Technological advances in drug research and development provide us with increasingly effective medicines that can be taken in correspondingly lower doses, yet still achieving longer term medicinal effects. While these advancements are of obvious benefit to patients, as they will receive fewer treatments with the added advantage of longer term...
Free Face Visors for Charities or Support Organisations
CTS is supplying free face visors to hospice charities or support organisations in need of them. If you know a hospice charity or support organisation that need these, please contact us. CTS Europe, in conjunction with Lanzon Design, have designed a self assembly, eco-friendly protective face visor and are currently manufacturing...
CTS Develops Mobile booth for COVID-19 Testing
A Mobile booth for COVID-19 Testing has been developed by CTS Europe Ltd in Portsmouth, UK. The booth enables the tester to perform tests efficiently and in complete separation between them and the patients. The test booth is a secure room with a positive pressure protective HEPA filtered environment to protect...
Podcast with The Leaders Council
The above recording is a Podcast with The Leaders Council. CTS Managing director, Sean Codling, discusses the topic of leadership and his own experience as the company's leader. The Leaders Council of Great Britain and Northern Ireland is a network of the nation's notable leadership figures. Through their online channels, Directors, CEO's...
Best Lab Contaiment Systems Manufacturer 2019
Following CTS’s nomination to The Global Health & Pharma (GHP) Technology Awards 2019. CTS are pleased to announce their success in wining 'Best Laboratory Containment Systems Manufacturer 2019' in the Medical Marijuana Awards and 'Best Laboratory containment Systems Manufacturer' for a second successive year, in the Technology Awards. The Healthcare...
MarketsandMarkets High Potent Medicines Conference 2019
MarketsandMarkets High Potent Medicines Conference 2019 addresses the challenges in the continual evolution of industry standards, technologies, and regulations. The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment that facilitate the safety of analysts from exposure. During this year's conference, Sean...
GHP Technology Awards Winner 2018
The 2018 Technology Awards, hosted by The Global Health & Pharma (GHP) have been determined and CTS Europe has been recognised as the GHP Technology Awards Winner 2018 in the categories of 'Best Laboratory Containment Systems Manufacturer of the Year 2018' and 'Best New Laboratory Safety Device' with their bench-mounted...